| Papers [1-15] of 100 :: [Page 1 of 7] | | Go to page : 1 2 3 4 5 6 7 —> | Search results on "JOHNSON CONTROLS DANA CORPORATION": |
|
|
Johnson Controls, Inc. and Dana Corporation, 2004.
Compares and contrasts the financial position of Johnson Controls, Inc. & Dana Corporation.
904 words (approx. 3.6 pages), 2 sources, APA, $ 31.95
»
Click here to show/hide summary
Abstract
This paper uses a financial ratio analysis as the basis of comparison of Johnson Controls, Inc. and Dana Corporation. A brief description of the two companies is included as well.
| |
|
Dana Corporation Capital Structure, 2004.
Provides insight into and an analysis of Dana Corporation's capital structure.
1,181 words (approx. 4.7 pages), 5 sources, APA, $ 40.95
»
Click here to show/hide summary
Abstract
This report attempts provides insight into Dana Corporation?s capital structure. The paper focuses on identifying the company's book value, market value, and the levered value. The report then demonstrates, through a quantitative analysis, what a twenty percent increase in assets will do for Dana Corporation, and assumptions are made to recommend an optimal capital structure mix. The analysis incorporates an estimation of Dana Corp's cost of capital, price per share, and the overall market value of the firm.
From the Paper
"The relationship of the stockholder's equity to total liabilities has been shown to be the most significant indicator of a company's solvency because it provides the ratio of capital provided by the stockholders as compared to capital provided through creditors. The information obtained through the analysis in this report provides answers to the ever important question of whether or not a company should issue stock or carry debt. Unsophisticated investors often wonder why a company would purposely carry debt and one excellent motivation derived from the Modigliani-Miller (M&M) model demonstrates that debt can and often is used as a shield against taxes. If a company like Dana decides, therefore, to carry debt, the tax shield would be used to lower overall costs. The next idea then is for a company like Dana to obtain an ideal or optimal mix between debt and equity."
| |
|
Johnson and Johnson, 2005.
A corporate analysis of the the company Johnson and Johnson.
1,564 words (approx. 6.3 pages), 6 sources, MLA, $ 51.95
»
Click here to show/hide summary
Abstract
The purpose of this paper is to introduce the reader to the Johnson and Johnson Corporation and its financial status. It begins with a brief history of the company and its products and its operational conditions. The paper also explores current methods to assess the company's financial condition which include looking at their annual report to analyze different financial indicators. The tools used are ratio analysis and leverage analysis with a brief explanation of how these tools work. It then evaluates the company by examining what they done to maximize their potential and what are they planning on doing in the future to remain solid. It concludes with recommendations for the company to maximize their potential.
Outline
Introduction
Operational Conditions
The Marketplace
Change and Expectation
Financial Conditions
Financial Highlights
Recommendation
From the Paper
"Johnson and Johnson does business within the healthcare sector and has industry membership in the major drug field. Because of the nature of this industry and the risk involved with drug manufacture, it can be very difficult to gage and predict its performance over time. Right now the drug industry is suffering the fallout from the recall of Celebrex. There are also other warnings being recently about other drugs such as Strattera. There has been much media scrutiny of the FDA and its prior approval of drugs like Accutane. What does this mean for the market and its companies? For the future, it may mean increased drug testing, which can be extremely costly, and time consuming."
| |
|
Johnson & Johnson: Social Responsibility, 2007.
Examines how the Johnson & Johnson company can be considered a model of corporate social responsibility.
6,050 words (approx. 24.2 pages), 15 sources, MLA, $ 143.95
»
Click here to show/hide summary
Abstract
This paper argues that Johnson & Johnson is a prime example of a company directed by "virtue ethics." As evidenced by the Tylenol crises, J&J executives do not resort to a moral calculus (Utilitarianism) or a deontological (rule-based) method of ethical decision making (Kant). The paper evaluates the company in terms of corporate control devices, stakeholder theory, the CSR pyramid, Kohlberg's theory of moral development and ethical theory.
Outline:
Introduction
Company History
The Tylenol Crisis
The Evaluation
References
From the Paper
"When all was said and done the recall of Tylenol* alone cost Johnson & Johnson over $100 million. Prior to the crisis, Tylenol held a 37% market share, outselling its four nearest competitors combined. Within weeks after the crisis its market share had dropped to 7%. When asked about the future of Tylenol, Madison Avenue guru Jerry Della Femina told a New York Times reporter "I don't think they (J&J) can ever sell another product under that name.""
| |
|
Johnson & Johnson, 2005.
This paper discusses the Johnson & Johnson company especially its major brand-drug Tylenol.
1,660 words (approx. 6.6 pages), 13 sources, MLA, $ 53.95
»
Click here to show/hide summary
Abstract
This paper explains that, since the 1885 partnership of the Johnson brothers, Johnson & Johnson has had a remarkable growth, world-wide especially, after World War II, when a plan of decentralizing operations was introduced, dividing the consumer market under the brand Johnson & Johnson and the professional markets under the current Ethicon brand label. The author points out that the Tylenol product not only has had problem with product tampering, which led to the introduction of tamper-proof packaging, but also this drug is deemed as having a narrower range between therapeutic and toxic than any other non-prescription drug especially for children. The paper concludes that, today, Johnson & Johnson is (1) a stable company with acceptable growth, but not as venturesome or dynamic in product innovations as some of its rivals and (2) is know as a family-friendly place to work with opportunities, especially for women and minorities.
From the Paper
"Saachi & Saatchi, one of the world's largest advertising agencies, handles some of Johnson & Johnson's consumer products advertising. Tylenol continues its campaign to promote its products as being used and recommended by health care professionals and used in hospitals more than any other "pain reliever". Pepcid AC has a strong campaign, positioned against other antacids as being able to be taken BEFORE a meal, as well as after. Feminine hygiene products are advertised most frequently in soap operas and other programming, aimed at women, of course. It is likely that in the coming year, the Nicorette brand anti-smoking products will increase their coverage, being outspent by rival Nicoderm. Rumors of a Nicorette product (perhaps a chewing gum) aimed at helping teens to stop smoking are not confirmed by the company."
| |
|
Johnson & Johnson, Inc., 2005.
This paper is a fundamental analysis of Johnson & Johnson, Inc., the world's most comprehensive and broadly based manufacturer of health care products and related services, for the consumer, pharmaceutical, medical devices and diagnostics markets.
3,960 words (approx. 15.8 pages), 10 sources, MLA, $ 107.95
»
Click here to show/hide summary
Abstract
This paper is a stock analysis of Johnson & Johnson, Inc. and their efforts at reducing costs, increasing market share, meeting their shareholders and stakeholders as well as industry expectations while still fulfilling the very high levels of quality demanded by their customers. The author uses the Capital Asset Pricing Model, which takes into consideration the inherent risk that is associated with any investment and the rates of return, to determine that Johnson & Johnson's return on investment must be greater than a return of 6.07 percent. The paper concludes that, through new acquisitions, novel business strategies and a regular migration to cheaper labor pools, Johnson & Johnson Inc has become a strong force to be reckoned with in the highly competitive major drugs and healthcare industry; the author recommends a buy order at $60. Illustration. Charts. Tables.
Table of Content
Introduction
Economic and Market Analysis
Globalization
Industry Analysis
Company Analysis
Brief History of the Company
Analysis of Capital Asset Pricing Model
Intrinsic Value
Recommendation and Conclusion
Appendix A: Valuation Measures
Appendix B: Trading Information
Appendix C: Competitors
Appendix D: Awards & Recognition
From the Paper
"The company has a long history of innovation and success. The founders created the first 'ready-made, ready-to-use surgical dressings' and initiated the way for 'application of the theory of antiseptic wound treatment' in the mid-1880's. These new products and services concepts literally reduced the threat of infection and disease in postoperative victims and helped save many lives in the early days of modern medicine. "The story begins with the discoveries of Sir Joseph Lister, a noted English surgeon, who identified airborne germs as a source of infection in the operating room. He called them, with grim aptness, the "invisible assassins." Medical science was beginning to understand, however imperfectly, the need for greater care in protecting the wound area."
| |
|
Corporate Governance and Corporate Law, 2002.
Examines the implications, factors and morals of corporate governance and corporate law.
2,900 words (approx. 11.6 pages), 5 sources, $ 106.95
»
Click here to show/hide summary
Abstract
This paper shall demonstrate how a quote from the U.K. summarizes corporate governance and corporate law through consolidating the diverse areas of the corporate governance system. This is achieved through investigating the factors that comprise corporate governance, in addition to the effects that corporate governance and corporate law have upon the business environment.
| |
|
Johnson & Johnson's Marketing Mix, 2006.
A review of Johnson & Johnson (JNJ), a recognized global leader and manufacturer of health care products.
3,003 words (approx. 12.0 pages), 5 sources, MLA, $ 88.95
»
Click here to show/hide summary
Abstract
This paper reviews and discusses the global leader in health care products, Johnson & Johnson (JNJ). According to the paper, JNJ has over 200 subsidiaries with offices in nearly every nation of the world. The paper reports that Johnson & Johnson has gone through a variety of structural and organizational structures in the last twenty years and today is centered on a market segment-based approach which comprises their consumer, medical devices & diagnostics and pharmaceuticals businesses.
Outline:
Company Description
Business Segments are aligned to Target Markets
Pharmaceutical Segment
Medical Devices & Diagnostics
Consumer
Product Strategy
Pricing Strategies
Distribution Strategy
Promotions and Marketing Communications
Conclusion
From the Paper
"JNJ's move into markets that require more sophistication in drug development and production is also exemplified by their move into the market for medications to treat Schizophrenia, an area of their business that made up 18% of total 2006 pharmaceutical revenues. The anemia market is another source of challenge for the company as price erosion has been necessary to stem market share losses. We assume revenue erosion in the mid-single digits over the next 3 years with continued competition from Amgen and some modest negative effects from Roche's Cera, expected to launch in May 2007. The anemia franchise (Procrit/Eprex) made up 14% of JNJ's pharmaceutical sales in 2006.
The MD&D division has enjoyed industry leadership, particularly at the company's Cordis business. This previously fast-growing business made up 20% of JNJ's MD&D sales in 2006 and a significant proportion of its profit. Noteworthy competition from Boston Scientific, Abbott, and Medtronic is likely to erode market share beginning in 2007, driving Cordis sales declines in the range of 4% to 19% in 2007-10. The Conor acquisition is expected to be successful.The Consumer division should benefit from the recent acquisition of Pfizer's consumer line."
| |
|
Johnson & Johnson, 2002.
A company overview of healthcare products producer Johnson and Johnson.
1,150 words (approx. 4.6 pages), 3 sources, $ 44.95
»
Click here to show/hide summary
Abstract
This five-page undergraduate paper studies the history of growth of one of the most well known healthcare companies; Johnson & Johnson. The company is known for its quality products and its innovative spirit; it has made significant contribution in the introduction of antiseptic practices in hospitals.
| |
|
Johnson & Johnson, 2004.
An analysis of the medical products company, Johnson & Johnson, including recent financial tables.
2,757 words (approx. 11.0 pages), 6 sources, MLA, $ 82.95
»
Click here to show/hide summary
Abstract
This paper presents a background and analysis of Johnson & Johnson. The paper begins with an explanation of J&J's business, which ranges from medical and health products to wider consumer products, such as talcum powder and cotton wool. The writer believes the company is an excellent example of a good, strong company that places consumer interests first.
Contents
Historical Background
Economic Foundation of the Company
Tables
Consumer Relations
References
From the Paper
"On the basis of information provided by Hoover?s (2003), in 1885, in Brunswick, NJ, James and Edward Mead Johnson founded their medical products company and were soon joined by their brother, Robert in 1886. Robert had developed an antiseptic surgical dressing that he wanted to have produced through the company. This represented the beginnings of one of the leading companies in a multitude of industries, including pharmaceutical manufacturing, medical devices and diagnostics manufacturing, and consumer products manufacturing. As Johnson & Johnson moved into the 20th century, the company continued to develop and manufacture products that would long come to be associated its? name."
| |
|
?Johnson & Johnson? as a Rational Organization, 2002.
An examination of the factors that give 'Johnson & Johnson, Co." a rational organizational structure.
980 words (approx. 3.9 pages), 3 sources, MLA, $ 34.95
»
Click here to show/hide summary
Abstract
The paper defines rational organizations as those which seek to develop structure and coordinate their activities in response to technical requirements and in relation to the complexity of the task environment they face. The paper shows how 'Johnson & Johnson' has established its mission and vision by putting in place a rational organizational structure, defining reporting relationships, establishing a project management methodology and infrastructure, developing a communications plan in support of the group's global leadership role, creating position descriptions, and recruiting. A history of the company is also discussed.
From the Paper
"Johnson & Johnson attributes the success of its organization structure to its management of each separate part as part of a functioning, single entity. By grouping its global affiliates into three business segments and then overlaying each segment and its affiliates with a transparent structure of alignment, Johnson & Johnson has created a unique organization structure."
| |
|
"Johnson and Johnson" and "Exxon": Public Relations, 1999.
Compares the causes and effects of the success of "Johnson and Johnson's" handling of the Tylenol cyanide tampering case and the failure of "Exxon"'s handling of the Alaska oil spill.
4,500 words (approx. 18.0 pages), 15 sources, $ 135.95
»
Click here to show/hide summary
From the Paper
"In 1982, the Johnson and Johnson Corporation suffered a major blow when one of their top selling products, Tylenol, was laced with cyanide while on store shelves and resulted in seven deaths in the Chicago area. The company responded immediately to the problem and launched a highly successful public relations campaign which averted any long-lasting damage to the company's image. On the other hand, after the Exxon Valdez oil spill in Alaska, Exxon responded so poorly and so slowly that the company still has not recovered its public image. This paper will look at the two disasters, how each company responded, and suggest a public relations strategy which will work for any major corporation placed in this situation.
In March of 1989, the Exxon Valdez, an oil tanker, ran aground on Bligh Reef, dumping 11 million gallons of crude oil..."
| |
|
Business Electronics Corporation vs. Sharp Electronics Corporation, 2002.
This paper is a law analysis of the case of Business Electronics Corporation vs. Sharp Electronics Corporation.
650 words (approx. 2.6 pages), 2 sources, $ 26.95
»
Click here to show/hide summary
Abstract
This paper assess the Dsitrct Court ruling and the Fifth Appeals Court of the Supreme Court. The author points out that we can see how the Sherman Act overturned a victory to the petitioner and made a case for fair pricing competition under the higher law of the land.
| |
|
Johnson & Johnson, 1994.
This paper is a financial analysis using liquidity ratios for 1990 to 1992 of Johnson and Johnson, the largest and most comprehensive health care company in the world: Debt, equity, profit margin. Tables.
1,125 words (approx. 4.5 pages), 7 sources, $ 39.95
»
Click here to show/hide summary
From the Paper
"Johnson and Johnson is the largest and most comprehensive health care company in the world, offering a broad line of consumer products, prescription and over-the-counter pharmaceuticals, and various other medical and dental items. Johnson and Johnson brands include Tylenol, Band-Aid and Reach. The company has a large international business (contributing 49 percent of sales in 1993) and is divided into three major operating segments: consumer, professional and pharmaceutical.. This research examines the company's financial performance for the period 1990 - 1992 through the use of ratio analysis. A complete table of the ratios used in this document is provided on page six.
Liquidity ratios are used to determine the ability of a company to meet its current (short-term) obligations. Common measure ... "
| |
|
Public Relations and Johnson & Johnson, 2005.
An examination of how Johnson and Johnson handled the crisis about the Tylenol medication.
1,208 words (approx. 4.8 pages), 5 sources, MLA, $ 41.95
»
Click here to show/hide summary
Abstract
This paper explains that when the crisis with Tylenol happened, in the 1980s, people were less in tune with public relations and the ramifications. The writer examines how the company dealt with the crisis and concludes that had this happened today, the results would have been far worse for the company.
From the Paper
"Johnson and Johnson has been a very broadly based organization that has been manufacturing health care products since a very long time. It started its footsteps as a child in the mid 1880s with the production of ready-to-use, ready-made surgical dressing. It was the first company to have applied the theory of wound treatment by use of antiseptics. With its application, the chances of infection in postoperative patients reduced greatly. General Robert Wood Johnson wrote the Company's Credo in 1943 which explained the responsible approach of Johnson and Johnson in carrying out their business. It states that the Company's initial most responsibility is to serve the people who make use of their services and products. Second in their priority list comes the employees followed by the environment and community and the last being the stockholders. This shows that Company had aimed to serve the consumers and wished to provide them with the best. It had also envisioned that if the first three priorities were met, the last one i.e. the stockholders, would be fulfilled automatically. "The philosophy at Johnson & Johnson is, 'All accidents and injuries are preventable. An accident is the end result of a unique chain of events and conditions. The role of all Johnson & Johnson employees is to foresee these acts and intercept them before they occur,' says Van Houten" (Smith, 2003). Health and safety are of utmost importance to Johnson and Johnson and they do not allow factors such as profits, sales and production to compromise the safety and health issues. During 1944, Johnson and Johnson became public from a privately held organization. Johnson and Johnson later realized its need to expand and diversify its business and during the 1950s, it entered into pharmaceuticals and later on produced Tylenol, a well known pain killer."
|
|
|
